Literature DB >> 15087244

Involvement of the pineal gland in diurnal cocaine reward in mice.

Murat Kurtuncu1, Ahmet D Arslan, Mustafa Akhisaroglu, Hari Manev, Tolga Uz.   

Abstract

Contribution of circadian mechanisms to the psychostimulant-induced behaviors has been suggested. The pineal gland is important component of circadian mechanisms. Using pinealectomized mice and sham-operated controls, we tested the contribution of pineal gland to the rewarding effects of cocaine in conditioned place preference test. Experiments were performed both during the day and at night. Controls with intact pineal glands demonstrated significant decrease in cocaine-induced conditioned place preference at night compared to daytime, whereas pinealectomized mice did not show any diurnal differences. Circadian mechanisms regulated by the pineal gland thus appear critically involved in cocaine-induced reward.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087244     DOI: 10.1016/j.ejphar.2004.03.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Photoperiodic suppression of drug reinstatement.

Authors:  B A Sorg; G Stark; A Sergeeva; H T Jansen
Journal:  Neuroscience       Date:  2010-12-24       Impact factor: 3.590

Review 2.  Drosophila, a genetic model system to study cocaine-related behaviors: a review with focus on LIM-only proteins.

Authors:  Ulrike Heberlein; Linus T-Y Tsai; David Kapfhamer; Amy W Lasek
Journal:  Neuropharmacology       Date:  2008-07-24       Impact factor: 5.250

Review 3.  MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

Authors:  Jiabei Liu; Shannon J Clough; Anthony J Hutchinson; Ekue B Adamah-Biassi; Marina Popovska-Gorevski; Margarita L Dubocovich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

4.  The muscarinic effect of anhydroecgonine methyl ester, a crack cocaine pyrolysis product, impairs melatonin synthesis in the rat pineal gland.

Authors:  Lívia Silva Medeiros de Mesquita; Raphael Caio Tamborelli Garcia; Fernanda Gaspar Amaral; Rafael Peres; Simone Miller Wood; RodrigoVincenzo de Luca Lucena; Eduardo Osório Frare; Mariana Vieira Abrahão; Tania Marcourakis; José Cipolla-Neto; Solange Castro Afeche
Journal:  Toxicol Res (Camb)       Date:  2017-03-29       Impact factor: 3.524

5.  Electroencephalographic signals synchronize with behaviors and are sexually dimorphic during the light-dark cycle in reproductive frogs.

Authors:  Ping Yang; Guangzhan Fang; Fei Xue; Jianguo Cui; Steven E Brauth; Yezhong Tang
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2013-12-12       Impact factor: 1.836

6.  Diurnal variation in nicotine sensitivity in mice: role of genetic background and melatonin.

Authors:  Sharon Mexal; William J Horton; Eric L Crouch; Sheila I B Maier; Andra L Wilkinson; Marisa Marsolek; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

7.  Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats.

Authors:  Tatiane T Takahashi; Valentina Vengeliene; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2017-02-28       Impact factor: 4.530

8.  The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

Authors:  Jonathan Henry W Jacobsen; Femke T A Buisman-Pijlman; Sanam Mustafa; Kenner C Rice; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

9.  Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.

Authors:  Shannon J Clough; Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  Physiol Behav       Date:  2014-05-09

10.  Food-induced reinforcement is abrogated by the genetic deletion of the MT1 or MT2 melatonin receptor in C3H/HeN mice.

Authors:  Shannon J Clough; Randall L Hudson; Margarita L Dubocovich
Journal:  Behav Brain Res       Date:  2018-01-31       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.